Zobrazeno 1 - 10
of 92
pro vyhledávání: '"RAAS, renin angiotensin aldosterone system"'
Publikováno v:
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6465-6470 (2021)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
The use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in coronavirus disease 2019 (COVID-19) patients has been claimed as associated with the risk of COVID-19 infection and its subsequent morbidities and
Autor:
Yahya Mohzari, Mushira Enani, Asma S. Albujaidya, Bandar Alosaimi, Nada M. Alkhani, Ahmed A. Alrashed, Mona A. Alanazi, Amal Ben-Akresh, Ahmad Alamer, Tahir Mehmood Khan, Syed Mohammed Basheeruddin Asdaq, Ivo Abraham, Malak Almutairi, Wafa Alfahad, Maram M. Alghalbi, Noara Alhusseini
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 6, Pp 726-733 (2021)
Journal of Infection and Public Health
Journal of Infection and Public Health
Background The uncertainty about COVID-19 outcomes in angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. This study aimed to determine the effect of ACEI/ARB use in patient
Autor:
John C. Burnett, Mark Ledwidge, Chris J Watson, Paul M. McKie, Kenneth McDonald, Valentina Cannone
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • Among subjects at risk for heart failure (Stage A and B), the minor C allele of the B-type natriuretic peptide (BNP) genetic variant rs198389 is associated with higher circulating levels of BNP. • Rs198389 C alle
Highlights • Among subjects at risk for heart failure (Stage A and B), the minor C allele of the B-type natriuretic peptide (BNP) genetic variant rs198389 is associated with higher circulating levels of BNP. • Rs198389 C alle
Publikováno v:
Sports Medicine and Health Science
Sports Medicine and Health Science, Vol 3, Iss 4, Pp 194-201 (2021)
Sports Medicine and Health Science, Vol 3, Iss 4, Pp 194-201 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mainly caused pneumonia and pulmonary fibrosis through upper respiratory tract infection, which resulted in acute respiratory distress syndrome (ARDS) and multiorgan damage of cardiovascula
Autor:
Kaixuan Yan, Yong Yang, Shuang Hua, Ying Xu, Xue Jiang, Jufei Li, Xianglu Rong, Danqi Zou, Dewei Ye
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 140, Iss, Pp 111685-(2021)
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Type 2 diabetes mellitus, obesity, hypertension, and other associated metabolic complications have been demonstrated as a crucial contributor to the enhanced morbidity and mortality of patients with coronavirus disease 2019 (COVID-19). Data on the in
Autor:
Carla Paolini, Alessandra Ferraglia, Anna Chiara Frigo, Giacomo Mugnai, Chiara Dalla Valle, Claudio Bilato, Andrea Volpiana
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 35, Iss, Pp 100821-(2021)
International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology. Heart & Vasculature
Highlights • Congestive heart failure is a major cause of morbidity and mortality worldwide. • Sacubitril/valsartan improved left ventricular remodeling and ejection fraction in a real-world setting, mostly within 12 months. • Female gender and
Autor:
Chelsey J. F. Smith, Lillian Benck, Michele A. Hamilton, Shivani Patel, Andrew R. Benck, David Chang, Emily K. Zern, Kevin S. Shah
Publikováno v:
JACC Case Reports
JACC: Case Reports, Vol 1, Iss 3, Pp 355-359 (2019)
JACC: Case Reports, Vol 1, Iss 3, Pp 355-359 (2019)
This report presents the case of this atypical presentation of a rare disease in a 19-year-old female with cardiomyopathy and hypertension. Investigation revealed renovascular stenosis, infarcts, and active vasculitis pathognomonic for Takayasu arter
Autor:
Iris Ma, Orianne Weizman, Thibaut Pommier, Cyril Zakine, A. Darmon, Melchior Jonveaux, Nacim Ezzouhairi, Théo Pezel, Wassima Marsou, Laura Geneste, Delphine Mika, C Fauvel, Antoine Deney, Thomas Delmotte, Baptiste Duceau, Vassili Panagides, Thomas Levasseur, Julien Ternacle, Clément Karsenty, Guillaume Bonnet, Victor Waldmann, Flavien Vincent, Marine Mevelec, Sabir Attou, Joffrey Cellier, Ariel Cohen, Antonin Trimaille, Diane Chavignier, Willy Sutter, Nathalie Noirclerc, Benjamin Perin
Publikováno v:
Archives of cardiovascular diseases
Archives of cardiovascular diseases, 2021, 114 (5), pp.415-425. ⟨10.1016/j.acvd.2021.04.003⟩
Archives of Cardiovascular Diseases
Archives of cardiovascular diseases, 2021, 114 (5), pp.415-425. ⟨10.1016/j.acvd.2021.04.003⟩
Archives of Cardiovascular Diseases
Summary Background Although cardiovascular comorbidities seem to be strongly associated with worse outcomes in patients with coronavirus disease 2019 (COVID-19), data regarding patients with preexisting heart failure are limited. Aims To investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ec58878d2b904283210ec9b80eb33c
https://hal.science/hal-04053120
https://hal.science/hal-04053120
Autor:
Yvonne Tami, Erin S. Morgan, George L. Bakris, Richard S. Geary, Adam E. Mullick, Kuolung Hu, Michela Brambatti, Sotirios Tsimikas
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • Targeting AGT is a novel approach to inhibit the RAAS pathway. • AGT is primarily synthesized in the liver. • IONIS-AGT-LRx is an ASO directed to hepatocyte-derived AGT. • In 2 phase 2 trials as monotherapy a
Highlights • Targeting AGT is a novel approach to inhibit the RAAS pathway. • AGT is primarily synthesized in the liver. • IONIS-AGT-LRx is an ASO directed to hepatocyte-derived AGT. • In 2 phase 2 trials as monotherapy a
Publikováno v:
Current Problems in Cardiology
Purpose of review: Although the respiratory system is the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is evident from recent data that other systems, especially cardiovascular and hematological, are also significan